Company news
ME Therapeutics Holdings, Inc. news in 2024
ME Therapeutics Holdings, Inc.'s news releases, calls and decks from 2024, newest first.
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update
October 22, 2024
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
September 18, 2024
ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells
July 8, 2024
CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING
June 13, 2024
ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial
May 29, 2024
ME Therapeutics to Present at Investor Clubhouse at the Canadian Open and Attend the 2024 BIO International Convention for Partnering Opportunities
May 17, 2024
ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024
April 15, 2024
ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV
March 26, 2024
ME Therapeutics Announces Closing of Non-Brokered Private Placement
March 6, 2024
ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update
February 27, 2024